Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead. Just over a week ago, Judge Vivian ...

Understanding the right dose of Ozempic for you can feel a bit confusing, especially if you’re just getting started. While ...

His oral medications prior to admission included topiramate 100 mg twice daily, ranitidine hydrochloride 75 mg twice daily, ferrous sulfate 325 mg twice daily, potassium chloride 10 meq once daily ...

Auto parts maker Magna International sees quarterly net income hit US$328 million ...